Status:
UNKNOWN
Efficacy of Puressentiel Protective Nasal Spray in Allergic Rhinitis
Lead Sponsor:
Puressentiel
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Allergic Rhinitis Due to Grass Pollen
Allergic Inflammation
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study is a proof o concept aiming to determine the efficacy of Puressentiel nasal protective spray (PNPS) in patients with allergic rhinitis. Cross over study, with a nasal provocative test (NPT...
Eligibility Criteria
Inclusion
- patients with diagnostic of allergic rhinitis sensitized to grass pollen for more than one year with or without associated asthma
Exclusion
- patients sensitized to a perrianual allergen
- patients with viral infection 4 weeks before inclusion
- patients with severe non controlled asthma
- patients with chronic sinusitis
- pregnancy or breast feeding
- patients with hypersensitivity to essential oil (eucalyptus radie)
- epileptic patient
- patients treated with nasal corticosteroid or anti-histamine
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04700852
Start Date
February 1 2021
End Date
September 30 2021
Last Update
January 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.